Management of neglected periorbital squamous cell carcinoma requiring orbital exenteration.
With its perineural invasion capacity, periorbital squamous cell carcinoma (SCC) may easily invade orbital structures. When SCC invades the orbital musculature or the orbit itself, orbital exenteration, one of the most disfiguring operations on the face, is required. We reviewed elderly patients with periorbitally localized SCC requiring orbital exenteration to evaluate reconstructive options and survival. A chart review of patients' records was conducted to identify all patients older than 65 years with periorbital malignancy requiring orbital exenteration from 2006 to 2011. A total of 9 patients who met the criteria were included in the study. The mean age at surgery was 77 ± 6.7 years, and the mean defect size was 74.2 cm2. All patients had a similar history of late presentation to a doctor because of hesitation to undergo surgery. The temporoparietal fascia flap, galeal flap, free gracilis flap, and free vastus lateralis musculocutaneous flap were the treatment options for reconstruction of the defects. All patients died during follow-up, and the mean survival was 15.7 months (range, 6-36 months). Only 2 of them had relapse before the death. Our small series suggest that elderly patients with periorbital SCC requiring orbital exenteration may not have enough survival to relapse because of the death from different causes without relapse or any sign of spreading cancer. Also, prolonged surgery with free flap reconstruction may increase the risk of postoperative intensive care unit requirement. Because local flaps may work very well for reconstructing the orbital exenteration defects, free flap option should be kept for selected cases.
From the Abant Izzet Baysal Universitesi, Tip Fakultesi, Plastic Cerrahi AD, Bolu, Turkey.
Furkan Erol
FE
Karabekmez
Muhammed Nebil
MN
Selimoglu
Ahmet
A
Duymaz
Mehtap Sen
MS
Karamese
Mustafa
M
Keskin
Nedim
N
Savaci
D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000556:secondary / Q000601:surgery*; D002423:Cause of Death; D003422:Critical Care; D005205:Fascia / Q000637:transplantation; D005260:Female; D005500:Follow-Up Studies; D058752:Free Tissue Flaps / Q000637:transplantation; D006760:Hospitalization; D006801:Humans; D007902:Length of Stay; D008175:Lung Neoplasms / Q000556:secondary; D008297:Male; D018482:Muscle, Skeletal / Q000637:transplantation; D064827:Myocutaneous Flap / Q000637:transplantation; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000601:surgery; D017233:Orbit Evisceration / Q000379:methods*; D009918:Orbital Neoplasms / Q000601:surgery*; D019651:Plastic Surgery Procedures / Q000379:methods*; D012189:Retrospective Studies; D016038:Skin Transplantation / Q000379:methods; D015996:Survival Rate